PolyPeptide Group AG (SWX:PPGN)
29.80
+0.10 (0.34%)
Apr 2, 2026, 5:30 PM CET
PolyPeptide Group AG Balance Sheet
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 74.59 | 68.28 | 95.71 | 37.53 | 136.3 |
Cash & Short-Term Investments | 74.59 | 68.28 | 95.71 | 37.53 | 136.3 |
Cash Growth | 9.25% | -28.66% | 155.03% | -72.47% | 692.09% |
Accounts Receivable | 64.31 | 86.26 | 78.78 | 49.15 | 67.79 |
Other Receivables | 22.66 | 21.2 | 17.21 | 13.27 | 8.14 |
Receivables | 86.96 | 107.46 | 95.98 | 62.41 | 75.92 |
Inventory | 154.25 | 146.35 | 128.51 | 145.07 | 113 |
Prepaid Expenses | 5.76 | 5.99 | 5.09 | 5 | 4.75 |
Other Current Assets | 3.32 | 0.14 | 1.32 | 1.56 | 1.63 |
Total Current Assets | 324.88 | 328.22 | 326.6 | 251.57 | 331.61 |
Property, Plant & Equipment | 458.79 | 388.99 | 324.11 | 297.29 | 235.44 |
Long-Term Investments | 7.51 | 5.16 | 5.24 | 2.77 | 3.47 |
Other Intangible Assets | 13.91 | 15.02 | 16.45 | 15.87 | 14.27 |
Long-Term Deferred Tax Assets | 19.31 | 17.62 | 16.69 | 8.29 | 10.26 |
Long-Term Deferred Charges | 1.56 | 1.56 | - | - | - |
Total Assets | 825.96 | 756.58 | 689.09 | 575.78 | 595.04 |
Accounts Payable | 74.31 | 73.26 | 60.91 | 45.93 | 28.48 |
Accrued Expenses | 28.22 | 22.54 | 24.02 | 17.19 | 20.48 |
Current Portion of Long-Term Debt | 1.91 | 31.91 | 42.48 | 1.1 | 1.15 |
Current Portion of Leases | 5.01 | 5.07 | 4.45 | 3.57 | 3.06 |
Current Income Taxes Payable | 1.58 | 0.36 | 0.23 | 0.07 | 4 |
Current Unearned Revenue | 74.17 | 60.48 | 42.97 | 27.54 | 46.13 |
Other Current Liabilities | 1.34 | 0.89 | 1.39 | 0.66 | 0.67 |
Total Current Liabilities | 186.53 | 194.5 | 176.45 | 96.05 | 103.96 |
Long-Term Debt | 118.47 | 48.93 | 58.98 | 9.41 | 10.3 |
Long-Term Leases | 15.98 | 18.98 | 18.87 | 17.65 | 14.95 |
Long-Term Unearned Revenue | 127.85 | 99.64 | 23.16 | - | - |
Pension & Post-Retirement Benefits | 29.85 | 32.13 | 25.11 | 26.64 | 38.98 |
Long-Term Deferred Tax Liabilities | 3.89 | 3.21 | 3.64 | 1.88 | 1.11 |
Other Long-Term Liabilities | 2.79 | 1.94 | 1.65 | 2.48 | 4.57 |
Total Liabilities | 485.36 | 399.33 | 307.86 | 154.11 | 173.87 |
Common Stock | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 |
Additional Paid-In Capital | 203.13 | 203.13 | 203.13 | 203.13 | 212.8 |
Retained Earnings | 122.63 | 140.48 | 165.14 | 214.15 | 196.03 |
Treasury Stock | -6.47 | -8.4 | -10.39 | -13.61 | -1.19 |
Comprehensive Income & Other | 21.01 | 21.73 | 23.05 | 17.71 | 13.23 |
Shareholders' Equity | 340.6 | 357.24 | 381.23 | 421.68 | 421.17 |
Total Liabilities & Equity | 825.96 | 756.58 | 689.09 | 575.78 | 595.04 |
Total Debt | 141.36 | 104.89 | 124.78 | 31.72 | 29.45 |
Net Cash (Debt) | -66.77 | -36.61 | -29.08 | 5.8 | 106.85 |
Net Cash Growth | - | - | - | -94.57% | - |
Net Cash Per Share | -2.02 | -1.11 | -0.88 | 0.18 | 3.33 |
Filing Date Shares Outstanding | 33.01 | 33 | 32.97 | 32.93 | 33.1 |
Total Common Shares Outstanding | 33.01 | 33 | 32.97 | 32.93 | 33.1 |
Working Capital | 138.34 | 133.72 | 150.15 | 155.52 | 227.65 |
Book Value Per Share | 10.32 | 10.83 | 11.56 | 12.81 | 12.72 |
Tangible Book Value | 326.69 | 342.23 | 364.77 | 405.81 | 406.91 |
Tangible Book Value Per Share | 9.90 | 10.37 | 11.06 | 12.33 | 12.29 |
Land | 142.33 | 147.37 | 129.94 | 124.02 | 87.67 |
Machinery | 363.09 | 319.81 | 243.43 | 201.16 | 170.55 |
Construction In Progress | 141.38 | 88.43 | 91.17 | 98.64 | 87.4 |
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.